• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

感染猿猴免疫缺陷病毒部分减毒nef缺失突变体的恒河猴的细胞免疫反应

Cellular immune response of rhesus monkeys infected with a partially attenuated nef deletion mutant of the simian immunodeficiency virus.

作者信息

Dittmer U, Nisslein T, Bodemer W, Petry H, Sauermann U, Stahl-Hennig C, Hunsmann G

机构信息

Department for Virology and Immunology, German Primate Center, Göttingen.

出版信息

Virology. 1995 Oct 1;212(2):392-7. doi: 10.1006/viro.1995.1496.

DOI:10.1006/viro.1995.1496
PMID:7571408
Abstract

To date the vaccines most successful in the simian immunodeficiency virus (SIV) model of AIDS are live attenuated viruses. However, the virus-specific immune response induced after infection of monkeys with attenuated SIV has not been described comprehensively. Therefore, we investigated the cellular immune response of eight rhesus macaques infected with a nef deletion mutant of SIVmac32H (pC8). In contrast to monkeys infected with pathogenic SIV, pC8-infected macaques developed a virus-specific T-cell proliferation. In addition, all animals showed a proliferative T-cell response to recall antigen and mitogens. In six of eight monkeys virus-specific cytotoxic T-cells directed against different SIV polypeptides were detected. In two animals, however, the truncated nef gene reverted to full length 12 weeks after pC8 infection. These two monkeys developed hematological alterations, indicating an immunodeficiency. Simultaneously with the onset of disease the animals lost their T-cell responsiveness against recall antigens. Eight weeks later their T-cell reactivity against mitogens was also abrogated. The results indicate that live attenuated SIV induced a virus-specific cellular immune response in monkeys which might be associated with the previously reported resistance to superinfection with pathogenic SIV. Paradoxically, if the attenuated SIV reverts in vivo to a more virulent virus, the SIV-specific immune response was inefficient to prevent the onset of immunodeficiency in the animals.

摘要

迄今为止,在艾滋病的猿猴免疫缺陷病毒(SIV)模型中最成功的疫苗是减毒活病毒。然而,用减毒SIV感染猴子后诱导的病毒特异性免疫反应尚未得到全面描述。因此,我们研究了8只感染SIVmac32H的nef缺失突变体(pC8)的恒河猴的细胞免疫反应。与感染致病性SIV的猴子不同,感染pC8的猕猴产生了病毒特异性T细胞增殖。此外,所有动物对回忆抗原和丝裂原均表现出增殖性T细胞反应。在8只猴子中的6只中,检测到针对不同SIV多肽的病毒特异性细胞毒性T细胞。然而,在2只动物中,pC8感染12周后,截短的nef基因恢复为全长。这两只猴子出现血液学改变,表明存在免疫缺陷。与疾病发作同时,动物失去了对回忆抗原的T细胞反应性。8周后,它们对丝裂原的T细胞反应性也被消除。结果表明,减毒活SIV在猴子中诱导了病毒特异性细胞免疫反应,这可能与先前报道的对致病性SIV重复感染的抵抗力有关。矛盾的是,如果减毒SIV在体内恢复为毒性更强的病毒,SIV特异性免疫反应在预防动物免疫缺陷发作方面是无效的。

相似文献

1
Cellular immune response of rhesus monkeys infected with a partially attenuated nef deletion mutant of the simian immunodeficiency virus.感染猿猴免疫缺陷病毒部分减毒nef缺失突变体的恒河猴的细胞免疫反应
Virology. 1995 Oct 1;212(2):392-7. doi: 10.1006/viro.1995.1496.
2
Cytotoxic T lymphocyte response against multiple simian immunodeficiency virusA (SIV) proteins in SIV-infected macaques.感染猴免疫缺陷病毒A(SIV)的猕猴体内针对多种SIV蛋白的细胞毒性T淋巴细胞反应。
J Immunol. 1992 May 1;148(9):2899-908.
3
The kinetics of specific immune responses in rhesus monkeys inoculated with live recombinant BCG expressing SIV Gag, Pol, Env, and Nef proteins.接种表达SIV Gag、Pol、Env和Nef蛋白的重组卡介苗活疫苗的恒河猴特异性免疫反应动力学。
Virology. 2000 Mar 1;268(1):94-103. doi: 10.1006/viro.1999.0131.
4
Chronology of genetic changes in the vpu, env, and Nef genes of chimeric simian-human immunodeficiency virus (strain HXB2) during acquisition of virulence for pig-tailed macaques.嵌合型猿猴-人类免疫缺陷病毒(HXB2株)在获得对食蟹猴的毒力过程中,vpu、env和Nef基因的遗传变化时间顺序。
Virology. 1998 Sep 1;248(2):275-83. doi: 10.1006/viro.1998.9300.
5
Limited viral spread and rapid immune response in lymph nodes of macaques inoculated with attenuated simian immunodeficiency virus.接种减毒猿猴免疫缺陷病毒的猕猴淋巴结中病毒传播受限且免疫反应迅速。
Virology. 1995 Nov 10;213(2):535-48. doi: 10.1006/viro.1995.0026.
6
SIV/HIV Nef recombinant virus (SHIVnef) produces simian AIDS in rhesus macaques.猴免疫缺陷病毒/人类免疫缺陷病毒Nef重组病毒(SHIVnef)可在恒河猴中引发猴艾滋病。
Virology. 1999 Dec 20;265(2):235-51. doi: 10.1006/viro.1999.0051.
7
Mycobacterium bovis bacille Calmette-Guérin enhances pathogenicity of simian immunodeficiency virus infection and accelerates progression to AIDS in macaques: a role of persistent T cell activation in AIDS pathogenesis.牛分枝杆菌卡介苗增强猕猴感染猿猴免疫缺陷病毒的致病性并加速其向艾滋病的进展:持续性T细胞活化在艾滋病发病机制中的作用
J Immunol. 1999 Feb 15;162(4):2204-16.
8
Molecular and biological characterization of simian immunodeficiency virus macaque strain 32H proviral clones containing nef size variants.含有nef大小变异体的猿猴免疫缺陷病毒猕猴株32H前病毒克隆的分子和生物学特性
J Gen Virol. 1994 Mar;75 ( Pt 3):529-43. doi: 10.1099/0022-1317-75-3-529.
9
Temporal loss of Nef-epitope CTL recognition following macaque lipopeptide immunization and SIV challenge.猕猴脂肽免疫和猴免疫缺陷病毒攻击后Nef表位细胞毒性T淋巴细胞识别的暂时丧失
Virology. 2000 Dec 20;278(2):551-61. doi: 10.1006/viro.2000.0671.
10
Long-lasting protection by live attenuated simian immunodeficiency virus in cynomolgus monkeys: no detection of reactivation after stimulation with a recall antigen.减毒活猴免疫缺陷病毒对食蟹猴的长期保护作用:再次接触抗原刺激后未检测到病毒再激活。
Virology. 1999 Apr 10;256(2):291-302. doi: 10.1006/viro.1999.9652.

引用本文的文献

1
Synthetic biology approach for the development of conditionally replicating HIV-1 vaccine.用于开发条件性复制HIV-1疫苗的合成生物学方法。
J Chem Technol Biotechnol. 2017 Mar;92(3):455-462. doi: 10.1002/jctb.5174. Epub 2017 Feb 2.
2
CD8+ lymphocytes do not mediate protection against acute superinfection 20 days after vaccination with a live attenuated simian immunodeficiency virus.接种减毒活猴免疫缺陷病毒疫苗20天后,CD8 +淋巴细胞不能介导针对急性重叠感染的保护作用。
J Virol. 2005 Oct;79(19):12264-72. doi: 10.1128/JVI.79.19.12264-12272.2005.
3
Comprehensive analysis of nef functions selected in simian immunodeficiency virus-infected macaques.
对感染猿猴免疫缺陷病毒的猕猴中选择的nef功能的综合分析。
J Virol. 2004 Oct;78(19):10588-97. doi: 10.1128/JVI.78.19.10588-10597.2004.
4
Immunization of rhesus macaques with a DNA prime/modified vaccinia virus Ankara boost regimen induces broad simian immunodeficiency virus (SIV)-specific T-cell responses and reduces initial viral replication but does not prevent disease progression following challenge with pathogenic SIVmac239.用DNA初免/改良安卡拉痘苗病毒加强免疫方案对恒河猴进行免疫,可诱导广泛的猿猴免疫缺陷病毒(SIV)特异性T细胞反应,并减少初始病毒复制,但不能预防致病性SIVmac239攻击后疾病的进展。
J Virol. 2002 Jul;76(14):7187-202. doi: 10.1128/jvi.76.14.7187-7202.2002.
5
Coreceptor phenotype of natural human immunodeficiency virus with nef deleted evolves in vivo, leading to increased virulence.缺失nef基因的天然人类免疫缺陷病毒的共受体表型在体内发生演变,导致毒力增强。
J Virol. 2002 Jul;76(14):6966-73. doi: 10.1128/jvi.76.14.6966-6973.2002.
6
Persistence of pathogenic challenge virus in macaques protected by simian immunodeficiency virus SIVmacDeltanef.致病性攻击病毒在受猿猴免疫缺陷病毒SIVmacDeltanef保护的猕猴体内的持续存在。
J Virol. 2001 Feb;75(3):1507-15. doi: 10.1128/JVI.75.3.1507-1515.2001.
7
Effects of in vivo CD8(+) T cell depletion on virus replication in rhesus macaques immunized with a live, attenuated simian immunodeficiency virus vaccine.体内CD8(+) T细胞耗竭对用减毒活猿猴免疫缺陷病毒疫苗免疫的恒河猴体内病毒复制的影响。
J Exp Med. 2000 Jun 5;191(11):1921-31. doi: 10.1084/jem.191.11.1921.
8
Evidence for recombination of live, attenuated immunodeficiency virus vaccine with challenge virus to a more virulent strain.减毒活免疫缺陷病毒疫苗与攻击病毒重组为更具毒力毒株的证据。
J Virol. 2000 Apr;74(8):3537-42. doi: 10.1128/jvi.74.8.3537-3542.2000.
9
Resistance to replication of human immunodeficiency virus challenge in SCID-Hu mice engrafted with peripheral blood mononuclear cells of nonprogressors is mediated by CD8(+) T cells and associated with a proliferative response to p24 antigen.在移植了非进展者外周血单个核细胞的SCID-Hu小鼠中,对人免疫缺陷病毒攻击的复制抗性由CD8(+) T细胞介导,并与对p24抗原的增殖反应相关。
J Virol. 2000 Feb;74(4):2023-8. doi: 10.1128/jvi.74.4.2023-2028.2000.
10
Immunization with live attenuated simian immunodeficiency virus induces strong type 1 T helper responses and beta-chemokine production.用减毒活猴免疫缺陷病毒进行免疫接种可诱导强烈的1型辅助性T细胞反应和β趋化因子的产生。
Proc Natl Acad Sci U S A. 1999 Nov 23;96(24):14031-6. doi: 10.1073/pnas.96.24.14031.